Deadly year for encephalitis feared in India
GORAKHPUR, India (AP) — A mosquito-borne disease that preys on the young and malnourished is sweeping across poverty-riven northern India again this monsoon season, with officials worried it could be the deadliest outbreak in nearly a decade....
POSTED 06/18/2013 at 04:18 AM -- 
|
Gender report of Shah Rukh Khan baby investigated
NEW DELHI (AP) — Health officials in Mumbai are investigating reports that Bollywood superstar Shah Rukh Khan and his wife know the sex of a baby they are having through a surrogate mother....
POSTED 06/18/2013 at 03:07 AM --
|
AstraZeneca picks site for new global home in Cambridge
By Ben Hirschler LONDON (Reuters) - AstraZeneca has chosen a science park on the southern outskirts of Cambridge, England, next to the world-renowned Addenbrooke's Hospital, for its new $500 million global headquarters and research center. Pro......
POSTED 06/18/2013 at 04:37 AM --
|
WHO urges tougher food marketing rules to curb childhood obesity
By Kate Kelland LONDON (Reuters) - The marketing of unhealthy foods to children has proven "disastrously effective", driving obesity by using cheap social media channels to promote fat-, salt- and sugar-laden foods, the World Health Orga......
POSTED 06/18/2013 at 07:28 AM --
|
'Drunk' claims upset Ukraine parliament budget hearing
KIEV (Reuters) - A parliamentary hearing on Ukraine's budget was suspended for several hours on Tuesday after opposition deputies alleged that a deputy finance minister presenting the budget report was drunk. Anatoly Myarkovsky, first deputy f......
POSTED 06/18/2013 at 10:11 AM --
|
GSK negotiating $1 billion sale of thrombosis drugs to Aspen
By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline is discussing the sale of its thrombosis drug brands Arixtra and Fraxiparine, along with a related French factory, to Aspen Pharmacare in a deal that could be worth some $1 billion. Britain's......
POSTED 06/18/2013 at 09:03 AM --
|
Special Report: For top U.S. lawyers, case in Guam is rare prize
By Joan Biskupic HAGATNA, Guam (Reuters) - Steven Levin lives alone on a boat docked off the coast of the Pacific island of Guam, about as far away from the U.S. mainland as an American resident can get. He has no wife or kids, no job, no phone or......
POSTED 06/18/2013 at 07:01 AM --
|
U.S. patent case climaxes with win for Canadian vibrator maker
WASHINGTON (Reuters) - Couples in the United States looking to spice up their sex lives will have to do without certain adult toys after a U.S. trade panel ruled on Monday that some companies are violating a patent held by a Canadian company for a......
POSTED 06/18/2013 at 11:07 AM --
|
Maine Democrats scramble after governor blocks Medicaid expansion
By Dave Sherwood BOWDOINHAM, Maine (Reuters) - Democratic legislators in Maine scrambled on Tuesday to muster the votes needed to override Republican Governor Paul LePage's late-night veto of a bill to expand Medicaid coverage to an additional......
POSTED 06/18/2013 at 12:33 PM --
|
AstraZeneca turnaround is 3-4 year journey, says CEO
By Ben Hirschler LONDON (Reuters) - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief executive said on Tuesday. Speaking as......
POSTED 06/18/2013 at 12:50 PM --
|
Enroll America sets private outreach for Obamacare enrollment
By David Morgan WASHINGTON (Reuters) - Enroll America, a nonprofit group at the center of the political fight over President Barack Obama's healthcare reform law, launched a multi-state grassroots campaign on Tuesday to help sign up millions o......
POSTED 06/18/2013 at 03:42 PM --
|
FDA probes deaths of two patients on Lilly schizophrenia drug
By Ransdell Pierson (Reuters) - The Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co's long-acting treatment for schizophrenia, Zyprexa Relprevv. Both patients died thre......
POSTED 06/18/2013 at 01:01 PM --
|
Exclusive: Japan's Astellas looks to sell dermatology assets - sources
By Jessica Toonkel NEW YORK (Reuters) - Japanese drugmaker Astellas Pharma Inc is looking to sell its dermatology portfolio, which could be worth between $500 million and $1 billion, according to three people familiar with the situation. Astellas ......
POSTED 06/18/2013 at 01:30 PM --
|
Industry-backed studies more prominent at meetings
By Genevra Pittman NEW YORK (Reuters Health) - Studies that are funded by pharmaceutical companies or involve industry-backed scientists tend to be more prominent at cancer meetings than independent studies, a new report suggests. "Figuring o......
POSTED 06/18/2013 at 03:11 PM --
|
Ohio residents held disabled woman in slavery, government charges
By Kim Palmer CLEVELAND (Reuters) - Three Ohio residents are accused of holding a cognitively disabled woman and her daughter against their will and forcing the woman to perform physical labor for them, threatening her with snakes if she didn'......
POSTED 06/18/2013 at 04:08 PM --
|
Naked gymnast faces charges over San Francisco transit stop antics
By Laila Kearney SAN FRANCISCO (Reuters) - A trained gymnast whose naked acrobatics and harassment of passengers at a San Francisco public transit station were captured on video and circulated widely on the Internet is facing criminal charges over......
POSTED 06/18/2013 at 04:49 PM --
|
MRI may help find infection from tainted injection
By Genevra Pittman NEW YORK (Reuters Health) - Some people who received potentially contaminated steroid injections may benefit from a MRI to check for signs of infection, a new study suggests - even if they don't have obvious symptoms. Resear......
POSTED 06/18/2013 at 04:14 PM --
|
Obamacare-like groups tied to lower costs: study
By Andrew M. Seaman NEW YORK (Reuters Health) - Large independent doctor practices that focus on primary care tend to spend less money and are more likely to meet guidelines for Americans on Medicare than smaller groups, according to a new study. ......
POSTED 06/18/2013 at 04:23 PM --
|
Past care tied to later treatment's success
By Andrew M. Seaman NEW YORK (Reuters Health) - If a person doesn't have much success with one pain treatment, they may say the next one they try doesn't work so great either, suggests a new study from Germany. Previous studies have found ......
POSTED 06/18/2013 at 04:46 PM --
|
U.S. court finds Novo Nordisk Prandin diabetes drug patent invalid
(Reuters) - A U.S. appeals court found the patent on Novo Nordisk's Prandin diabetes drug in combination with metformin to be invalid, paving the way for introduction of a generic version of the medicine, the Danish drugmaker said on Tuesday. ......
POSTED 06/18/2013 at 04:25 PM --
|
